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ARTICLE
Tissue engineering of human hair follicles using a
biomimetic developmental approach
Hasan Erbil Abaci1, Abigail Coffman1, Yanne Doucet1, James Chen1,2, Joanna Jacków1, Etienne Wang1,
Zongyou Guo1, Jung U. Shin1, Colin A. Jahoda3 & Angela M. Christiano1,4
Human skin constructs (HSCs) have the potential to provide an effective therapy for patients
with signiﬁcant skin injuries and to enable human-relevant drug screening for skin diseases;
however, the incorporation of engineered skin appendages, such as hair follicles (HFs), into
HSCs remains a major challenge. Here, we demonstrate a biomimetic approach for gen-
eration of human HFs within HSCs by recapitulating the physiological 3D organization of cells
in the HF microenvironment using 3D-printed molds. Overexpression of Lef-1 in dermal
papilla cells (DPC) restores the intact DPC transcriptional signature and signiﬁcantly
enhances the efﬁciency of HF differentiation in HSCs. Furthermore, vascularization of hair-
bearing HSCs prior to engraftment allows for efﬁcient human hair growth in immunodeﬁcient
mice. The ability to regenerate an entire HF from cultured human cells will have a trans-
formative impact on the medical management of different types of alopecia, as well as
chronic wounds, which represent major unmet medical needs.
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Skin is a complex organ that contains more than 50 differentcell types that comprise the core epidermal, dermal, andhypodermal tissues, as well as various other components,
including vasculature, sensory neurons, the skin immune system,
and appendages, such as hair follicles (HFs). Each year, more than
six million patients are hospitalized in the U.S. for signiﬁcant skin
loss or disﬁgurement due to thermal and pressure injuries,
chronic diabetic ulcers or genetic blistering skin diseases1. The
ability to generate bioengineered human skin constructs (HSCs)
has provided a promising skin replacement therapy for these
patients2 and allowed for human-relevant drug screening to target
skin disorders3.
Currently available HSCs still have signiﬁcant limitations
including poor long-term viability and lack of appendages, such
as HFs, which play roles in thermoregulation, barrier function,
and wound healing4. Our group recently improved the viability of
skin grafts by establishing a method to micropattern induced
pluripotent stem cell (iPSC)-derived vasculature in HSCs5.
However, the incorporation of HFs into engineered HSCs
remains a major challenge and limits their potential for regen-
erative medicine and preclinical drug testing.
Dermal papilla cells (DPCs) are highly specialized mesenchy-
mal cells that are indispensable for HF morphogenesis and
cycling. Previous studies have shown proof-of-concept for indu-
cing human hair growth in mice through intracutaneous trans-
plantation of intact DPCs and epithelial cells6. However,
transforming this concept into a feasible therapeutic strategy
requires large numbers of human DPCs, which raises a number of
challenges due to the paradoxical rapid loss of hair inductivity of
DPCs when expanded in 2D in vitro culture7,8. Various
approaches have been used to restore the inductive characteristics
of DPCs, such as co-culture with keratinocytes9, use of small
molecules8, and hypoxia culture10. We previously showed that
3D-spheroid culture of DPCs could partially restore their intact
transcriptional signature7. This method allowed us and other
groups11 to induce human hair formation using cultured DPC
spheroids in mice, albeit inefﬁciently due to high levels of
variability in the hair inductive properties of DPCs.
Using a systems biology approach, we also identiﬁed several
master regulator (MR) genes of inductive DPC identity, which
could potentially be used to achieve complete restoration of hair
inductive transcriptional signature of DPCs7. Similarly, we
recently reported that Jak inhibitors also directly restore hair
inductivity in treated DPCs in culture12. Following these sub-
stantial steps towards restoring intact DPC identity, we postulated
that generation of de novo HFs in HSCs requires both signiﬁcant
reprogramming of the DPC transcriptional signature, as well as
accurate recapitulation of critical microenvironmental cues, such
as epithelial−mesenchymal and cell− extracellular matrix
interactions.
In this study, we present an innovative biomimetic approach
for effective generation of human HFs within HSCs by recapi-
tulating the physiological 3D conformation of cells in the HF
microenvironment. We exploit the unique capability of 3D-
printing technology to create structures with high aspect ratios
(length to width ratio: ~100 for human HFs13), which was not
possible with previous microfabrication techniques, such as soft
lithography. Our approach permits controllable self-aggregating
spheroid formation of DPCs in a physiologically relevant extra-
cellular matrix and initiation of epidermal−mesenchymal inter-
actions, which results in HF formation in HSCs in vitro. Further,
vascularization of hair-follicle-bearing HSCs increases graft sur-
vival and enables efﬁcient human hair growth in mice. Our
method represents a novel bioengineering strategy for feasible
generation of hair-bearing HSCs entirely ex vivo from cultured
human cells.
Results
Controlling 3D spatial arrangement of cells in HSCs. Human
DPC spheroids have the potential to induce de novo hair for-
mation when placed in contact with human epidermis in mice7,11.
However, when spheroids were placed in HSCs and maintained
in culture, they rapidly dissociated into the collagen matrix over
several days and did not initiate the epidermal−mesenchymal
interactions required for HF morphogenesis (Supplementary
Figure 1). In agreement with previous studies14, this observation
indicated that simple engineered HSCs do not provide a phy-
siological microenvironment sufﬁcient to induce HF formation.
To control the spatial arrangement of cells in HSCs, we used
3D-printing technology and microfabricated plastic molds that
contain HF-shaped extensions that are adjustable in diameter,
length, and density (Fig. 1a, b). These molds were used to create
an array of microwells on a type I collagen gel containing dermal
ﬁbroblasts (FBs) (Fig. 1c). Seeding DPCs over these microwells
led to spontaneous aggregate formation in the base of the
microwells overnight (Fig. 1d, e). This method allowed for precise
control of DPC aggregate size by adjusting the diameter of the
microwells (Fig. 1f). The spontaneous aggregate formation
restored the expression of versican (VCAN) and alkaline
phosphatase (ALP) activity and suppressed the expression of
smooth muscle actin (SMA), a protein only expressed in 2D
cultures of DPCs but not in intact DP in vivo (Fig. 1g). These
changes were not observed in FB aggregates (Fig. 1h), which we
used as a negative control throughout the study. The 3D-printing
approach allowed us to generate HSCs with different HF
densities, such as 19 and 81 HF per cm2 (Fig. 1i), and to achieve
an in vivo-like DPC phenotype in 3D-reconstructed dermis.
Induction of hair follicle differentiation in HSCs. To establish a
physiological conformation of cells, we seeded keratinocytes
(KCs) over the dermal constructs and allowed the cells to settle
down and ﬁll up the microwells, engulﬁng the DPC aggregates
(Fig. 2a, b) and forming an overlying column of KCs that
resembled a hair follicle-like unit (HFU). We conﬁrmed the
sustained activity of ALP in DPCs after the addition of the KCs.
Cross-sections of the whole constructs exhibited ALP activity at
the base of the HFUs (Fig. 2c, d), where the DPC aggregates with
ALP activity and VCAN expression were surrounded by K5-
positive KCs (Fig. 2e, f). Reﬂecting the physiological proximity
and conformation of epidermal and mesenchymal cells, KCs
directly above the DPC aggregates showed differentiated mor-
phology resembling KCs in the HF after a few days in culture
(Fig. 2g), whereas no morphological changes were observed with
the FB control (Fig. 2h). Culturing the 3D skin constructs for a
week resulted in the differentiation of KCs into speciﬁc hair
lineages, including Keratin-5 (K5) (an outer root sheath marker),
AE13, AE15 and K71 (inner root sheath markers), and K75 (a
hair medulla and companion layer marker) (Fig. 2i−l). When the
same experiments were performed with FB aggregates as a con-
trol, KCs remained in their undifferentiated state by retaining the
expression of K5, and failure to express the hair lineage markers,
AE13 or K75 (Fig. 2m, n). In these analyses, we did not observe
differentiation of KCs into the sebocyte lineage as evident by the
absence of Oil-red-O staining within the follicular structures
(Supplementary Figure 2).
Extending the culture period from 1 week to 3 weeks in vitro
led to the elongation of the HFs down into the dermis and a
better organization of the inner and outer root sheath layers
(Fig. 2o). Interestingly, the HFs spontaneously repositioned their
orientation from an initial angle of 90 degrees to a more
physiological obtuse angle (>120 degrees) after 3 weeks of culture
in vitro (Fig. 2o). Remarkably, in some of our constructs, we
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observed hair ﬁbers protruding from the surface of the HSCs
(Fig. 2p, q). Although at this stage, this process was relatively
inefﬁcient and was only observed approximately in one out of
three constructs. However, to our knowledge, this is the ﬁrst
demonstration of the generation of human HFs in HSCs in an
entirely ex vivo context.
Improvement of HF induction by genetic reprogramming. In
our HSCs, we found that the ratio of the HFUs demonstrating HF
differentiation to the total number of HFUs (success rate) was as
low as 19%, perhaps due in part to incomplete restoration of DPC
hair inductive gene signature (~22%) achieved solely through 3D
aggregate formation7. Therefore, to further enhance hair induc-
tivity, we leveraged two MR genes, Lef-1 and Fli-1, which we
previously identiﬁed as the key regulators of the intact DPC gene
signature7. Interestingly, our previous systems biology approach
showed that both spheroid culture of DPCs and Fli-1 over-
expression restored very similar expression proﬁles7. In contrast,
Lef-1 targeted genes that were not restored by spheroid culture,
suggesting that Lef-1 overexpression and spheroid culture are
complementary for restoration of the DPC hair inductive tran-
scriptional signature.
To test this hypothesis, we performed transient transfection of
Lef-1 in cultured DPCs (passage 3) (Supplementary Figure 3), and
then formed spheroids with Lef-1-transfected cells. We compared
their gene expression proﬁles to DPCs transfected with an empty
vector control, as well as freshly isolated DP using RNA-
sequencing. The Lef-1 downstream network genes predicted
previously by the ARACNE algorithm were experimentally
validated by overexpression of Lef-1 in cultured DPCs via gene
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Fig. 1 Patterning of collagen type-1 gel using 3D-printed molds allows for physiological arrangement of cells in the hair follicle. Hair follicle molds were
designed (a) and 3D-printed (b) to have HF-like extensions and a 5-mm-deep cavity that allows the molds to ﬂoat on collagen gel. c The collagen gel
containing dermal ﬁbroblasts was allowed to solidify around the HF-like extensions to create an array of microwells in which the DPCs formed spontaneous
aggregates. d Top view of HSCs containing DPCs which settled down into the microwells (lower panel: higher magniﬁcation of the microwells). e DPCs
formed spontaneous aggregates at the center of the microwells (dashed line circles the aggregates). f The size of DPC aggregates, as calculated from
images, was correlated with the diameter of the microwells (500 µm wells in red and 700 µm wells in blue) (n= 9; three technical and three biological
replicates). Expression of SMA and VCAN and the activity of ALP in 2D cultures of DPCs and in DPCs aggregates formed in the microwells (g) was
compared to 2D cultures of FBs and FB aggregates in the microwells (h). i Top view of the 3D-reconstructed dermis at two different hair follicle densities of
19 HF per cm2 and 81 HF per cm2. Scale bars for (d) and (e−h) are 100 µm and 5 mm for (b) and (i)
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set enrichment analysis (GSEA), yielding a normalized enrich-
ment score (NES) of 3.45 and a p value (two-tailed t test) of
2.8×10-4 (Fig. 3a). Gene distance matrix (Fig. 3b) and hierarchical
clustering analyses (Supplementary Figure 4) showed that Lef-1
overexpression and 3D-spheroid culture synergistically restored
the intact DPC gene signature. Skin constructs generated with
DPCs overexpressing Lef-1 resulted in signiﬁcant increase (up to
13-fold) in the expression of the speciﬁc hair lineage genes,
including the outer and inner root sheath (K17, K71, K25), and
hair companion and medulla markers (K75), compared to the
DPCs transfected with empty vector (Fig. 3c). HSCs made with
FB aggregates did not exhibit any expression of the inner root
sheath genes, K71 and K25, as expected. The fold differences in
Fig. 3c were normalized to the expression of the genes in HSCs
based on the empty vector-transfected DPCs. Similarly, Lef-1
overexpression in DPCs markedly increased the percentage of the
HFUs with KC differentiation (Fig. 3d), increasing the success
rate of HF induction markers from 19 to 70% (Fig. 3e, f, i).
To extrinsically recapitulate the role of Lef-1, we treated the
constructs with recombinant human Wnt10b and CHIR99021, a
small molecule that activates Wnt-signaling through inhibition of
GSK3. Treatment with these factors (instead of Lef-1
FB DPC KC
a
DP FB
FB control
FB control
FB control
K14
K5/AE13 K5/AE13
K71 K75 K75 /AE15
K5/AE13
ALP ALP/K5 Versican
c
ed
g h
i
k
m
n
p
o
DP
DP
Epidermis
Dermis
z
x
y
j
K5/AE15
b
ALP
DPDP
DP
DP FB
FB
f
l
q
Fig. 2 Differentiation of human keratinocytes into speciﬁc hair follicle lineages in HSCs. a Schematic and b 3D-reconstructed image of K14-positive cells
showing microwells ﬁlled with KCs after a day of culture. c Cross section of the whole HSCs with the ALP-active labeled cells at the tip of the microwells
(black arrows). Bright-ﬁeld (d) and e, f immunoﬂuorescent images of HSCs reveal the physiological conformation of cells where ALP-active and VCAN
expressing DPCs (dashed circles) are engulfed by K5-positive KCs after a day of culture, forming HFUs. H&E staining of HSCs depicted the morphological
changes of KCs above DPC aggregates (g), which was not observed in HSCs with FB aggregates (h). KCs in the HSCs expressed speciﬁc hair lineage and
differentiation markers K5 and AE13 (i), AE15 (j), K71 (k), and K75 (l), which was not observed in HSCs with FB aggregates (m, n) after a week of culture.
o Culture of HSCs for 3 weeks resulted in elongated hair follicles and improved organization of inner and outer root sheaths as shown by the K5 and AE13
markers, respectively. p, q Prolonged culture period led to hair ﬁber formation and protrusion from the HSCs (arrow heads indicate the hair ﬁber). Scale
bars for (b), (c) and (o−q) are 2mm and for (d−n) are 100 µm (n= 9; three technical and three biological replicates)
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overexpression) also increased the success rate up to ~50%, albeit
lower than that was achieved with Lef-1 overexpression, high-
lighting the Wnt-signaling-independent role of cellular repro-
gramming (Fig. 3g−i).
The exogenous expression of the other MR gene, Fli-1, resulted
in signiﬁcant reprogramming of the gene expression in cultured
DPCs (Supplementary Figure 5a) and upregulated several Fli-1
downstream network genes, such as collagen 5 (COL5) and
collagen 6 (COL6) (Supplementary Figure 5b), in agreement with
our previous gene network analyses. Although Fli-1 overexpres-
sion in DPCs induced HF differentiation in HSCs (Supplemen-
tary Figure 5c) with a success rate of 21%, it did not signiﬁcantly
improve the induction achieved by empty-vector-transfected
DPCs (Fig. 3i). Overall, these data supported our previous
predictions that Fli-1 overexpression and spheroid formation
have an overlapping effect in DPC reprogramming, whereas Lef-1
overexpression complements aggregate formation and signiﬁ-
cantly improves the restoration of DPC hair inductivity.
Generation of vascularized HSCs with high-follicle density. We
next examined the capability of our HSCs containing Lef-1-
transfected DPCs to grow human hair in vivo by grafting them
onto immunodeﬁcient nude mice. To more closely recapitulate
the physiological hair density in human scalp13, we increased the
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Fig. 3 Overexpression of the master regulator gene Lef-1 in DPCs enhances the efﬁciency of hair follicle induction in HSCs. a GSEA of the RNA-sequencing
data of Lef-1-transfected DPCs revealed that Lef-1 overexpression signiﬁcantly overlaps the downstream network genes previously predicted by ARACNE
algorithm (NES, normalized enrichment score). b Gene distance matrix showing the individual and synergistic effects of Lef-1 overexpression and 3D-
spheroid culture in DPC transcriptional signature (2D: adherent culture; 3D: spheroid culture; 2DL: adherent culture of Lef-1-transfected cells; 3DL: spheroid
culture of Lef-1-transfected cells). c Expression levels of speciﬁc hair follicle layers and Wnt-signaling genes determined by qPCR from the total mRNA of
HSCs containing Lef-1-transfected DPCs (green), empty vector-transfected DPCs (blue) and FBs control (black). Fold difference values are based on the
empty vector-transfected DPCs. d Low magniﬁcation image demonstrating expression of AE13 in HSCs generated using Lef-1-transfected DPCs and the
high efﬁciency in HF lineage differentiation. Histological H&E staining of the constructs generated by empty vector-transfected DPCs (e), Lef-1-transfected
DPCs (f), Wnt10b-treated DPCs (g), and CHIR99021-treated DPCs (h) (arrows showing differentiated KC morphology). i Success rate, deﬁned as the ratio
of the HFUs exhibiting hair follicle differentiation to the total number of HFUs, for HSCs with DPCs at different treatment conditions compared to FB control
(n= 3 with cells from three donors, *p < 0.05 and **p < 0.005 from two-tailed t test); Center values and error bars are deﬁned as means and s.e.m.; Scale
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HF density from 81 HF to 255 HF per cm2 (Fig. 4a−c and
Supplementary Movie 1) using 3D-printed high HF density
molds. The ﬁrst set of experiments did not result in hair for-
mation; instead, we observed substantial necrosis at the center of
the grafts due to lack of host vascularization in the grafts (Sup-
plementary Figure 6a, b), consistent with our previous work5.
To generate a vascular bed, we encapsulated GFP-tagged
human umbilical vein endothelial cells (HUVECs) in the dermis
of our HSCs together with the dermal ﬁbroblasts (Fig. 4d).
Culturing the constructs at a HUVEC to FB ratio of 16:1, we
induced spontaneous capillary formation in the dermis (Fig. 4e).
Immunoﬂuorescent wholemount imaging of the constructs
revealed that these capillary-like structures were in close
proximity to the HFs (Fig. 4d). Grafting the vascularized HSCs
onto mice promoted host vascularization into the grafts (Fig. 4f).
GFP-tagged HUVECs formed more organized and elongated
networks upon grafting, which were located in close proximity to
the host red blood cells and newly formed host vessels of the mice
that were labeled with mouse-speciﬁc rhodamine-conjugated
Isolectin Griffonia simplicifolia (GS-IB4) (Fig. 4g, h), and also
exhibited lumen formation (Fig. 4i).
Hair induction in HSCs grafted onto mice. Four to ﬁve weeks
after grafting our vascularized HSCs at a high follicle density of
255 HF per cm2 onto immunodeﬁcient nude mice, we observed
substantial hair growth in the grafts, whereas the HSCs prepared
with FB aggregates did not induce hair formation (Fig. 5a, b). In
the grafting experiments, we used ten mice per condition. Our
vascularization strategy enabled the survival of seven out of ten
grafts, both for HSCs prepared with DPCs as well as FBs as a
negative control. Grafts from four out of these seven mice suc-
cessfully generated human HFs, whereas none of the seven mice
in the FB control experiment induced hair formation. Immu-
nostaining with a human-speciﬁc nuclear antibody conﬁrmed
that these HFs were comprised of differentiated human KCs and
DPCs, as indicated by K71 (Fig. 5c) and VCAN (Fig. 5d) staining,
respectively. In addition, we did not detect any presence of der-
mal sheath (DS) around the engineered HF, as evidenced by
negative SMAα staining (Supplementary Figure 7a), whereas the
mouse hair showed expression of SMAα around DPCs marked
with Lef-1 (Supplementary Figure 7b). These data suggest that
DPCs and KCs are sufﬁcient to grow de novo HFs without the
presence of DS, although DS may be required for the long-term
support and maintenance of the HFs at later stages. Low mag-
niﬁcation images of the human-speciﬁc nuclear staining and K14
(stain appears in multiple layers due to tilted angle of the con-
structs) clearly delineated the edges between the host and grafted
skin, and most of the regions of the mouse skin lacked HFs
(Fig. 5e). Our grafts have only a slightly thicker epidermis than
the mouse, consistent with our grafting strategy and timing, in
which we chose to not cornify the epidermis at high calcium
conditions to avoid any interference with HF differentiation (as
opposed to epidermal differentiation) prior to grafting. Therefore,
further epidermalization and corniﬁcation seen in Fig. 5e took
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Fig. 4 Vascularization of high hair-follicle-density HSCs for efﬁcient engraftment. a, b HSCs were generated using the molds that have 255 HF per cm2 to
promote hair growth in grafts. c 3D-reconstructed wholemount image of the HSCs showing 3D conformation of K14-positive cells at the high hair follicle
density. GFP-tagged HUVECs that were encapsulated in the dermal compartment with the ﬁbroblasts closely surrounded the K14-positive cells in the hair
follicle structures (d) and formed capillary-like networks after 3 days of culture (e). f Bottom view of the explanted prevascularized HSCs (dashed circle)
with GFP-HUVECs showing promoted host vascularization and blood supply to the grafts (n= 9; three technical and three biological replicates); g HSCs
grafted onto mice were revascularized by the host vessels where GFP-tagged HUVECs (green) formed capillaries that are well-organized around the
mouse vessels (GS-IB4 staining in red; arrow heads show the proximity of mouse and human vessels) and red blood cells (RBCs) (h), (arrow heads show
host RBCs near human blood vessels and lower panel shows a magniﬁed area of the image); and exhibited lumen formation (arrow heads show the lumen)
(i). Scale bars for (b and f), (c, d), and (e, g, h and i) are 4 mm, 2mm, and 100 µm, respectively
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place after grafting onto mouse, suggesting that epidermal dif-
ferentiation could be controlled by the host microenvironment.
Microscopic bright-ﬁeld images of the hair ﬁbers showed that
engineered hair (Fig. 5g) closely resembles the morphology of
human terminal hair (Fig. 5f); and moreover, that it represented
an intermediate thickness between human terminal and vellus
hair (Fig. 5h). To conﬁrm the human origin of the de novo HFs,
we selectively isolated the RNA of the cells from the HFs within
the grafts using laser capture microdissection (Supplementary
Figure 8a, b) and performed PCR using human vs. mouse-speciﬁc
primers (see Supplementary Table 1)15. The PCR analyses with
both sets of primers conﬁrmed that HFs in the grafts highly
expressed the human-speciﬁc sequence, whereas the control
whole mouse skin tissue only expressed mouse-speciﬁc genes
(Fig. 5i), demonstrating that the HFs induced in the grafted HSCs
are indeed derived from human cells. We also observed low levels
of mouse-speciﬁc gene expression in the HFs, consistent with
presence of some cells in the grafts that are negative for human-
speciﬁc nuclear staining (Fig. 5c−e). These cells may represent
recruitment of mouse vasculature and inﬁltrating cells to the
microenvironment of the HFs, since the levels of mouse-speciﬁc
gene expression were much higher in the whole grafts compared
to the laser captured HFs (Fig. 5i).
Discussion
Tissue engineering of human HFs has been a long-standing
challenge and its progress has lagged behind other lab-grown
tissues, such as vasculature16 and intestinal epithelium17. This is
mainly due to the lack of availability of a platform that can
successfully recapitulate the microenvironmental cues required to
maintain the requisite cell interactions for hair neogenesis.
Recently developed 3D-printing technology has allowed for
creation of structures with high aspect ratios (length to width
ratio: ~100 for human HFs13), which was not possible with
previous microfabrication techniques, such as soft lithography.
Utilizing this capability, we generated HF-like microwells in 3D-
reconstructed dermis where genetically/extrinsically repro-
grammed cells could be arranged easily into a physiologically
relevant conformation, forming HFUs. This biomimetic approach
led to KCs differentiation into speciﬁc hair lineages and allowed
us to generate human HFs within HSCs in an entirely ex vivo
context.
Since the animal body offers a physiological environment for
the development and engraftment of animal/human tissues, the
ﬁrst demonstration of fully regenerated organs typically involves
transplantation of tissues onto animals. For instance, creating de
novo adult HFs from cultured cells dates back to 1984, where
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Fig. 5 Induction of human hair growth in immune-deﬁcient nude mice. a, b Engraftment of high follicle-density HSCs onto immune-deﬁcient nude mice led
to hair growth in the grafts after 4–6 weeks (b), which was not observed in the HSCs prepared with FB aggregates as a control (a) (n= 10; ﬁve biological
and two technical replicates per each condition). c, d Human-speciﬁc nuclear staining (green) indicated that the de novo hair follicles marked with K71 (c)
(HF boundaries circled in dashed line) and DPCs marked with VCAN (d) are comprised of human cells (DPs circled in dashed line). e Low magniﬁcation
image of the explanted grafts revealed the boundaries (dashed line) between the mouse and human tissues as marked by the human nuclear staining.
Bright-ﬁeld microscopy of unpigmented terminal human hair (f), engineered human hair in the grafts (g), and unpigmented human vellus hair (h) showed
morphological similarities between human hair and engineered hair. i PCR was performed with two sets of primers speciﬁc to human and mouse cells using
the RNA of the laser captured hair follicles from the grafts in comparison to whole grafts, mouse skin, and cultured human KCs. Scale bars for (a, b), (c−e)
and (f−h) are 2mm, 200 µm, and 50 µm respectively
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cultured rodent HF DPCs induced hair growth in recipient skin18.
The same group was the ﬁrst to achieve hair growth in recon-
structed follicles in culture19. Similarly, two recent studies
established the growth of mouse hair in vivo through encapsu-
lation of mouse iPSCs20 or mouse adult DPCs and epidermal
cells21 in hydrogels followed by transplantation of these in vitro-
conditioned structures into mice. Another recent study also
demonstrated the spontaneous formation of HFs in embryoid
bodies of mouse iPSCs22.
Despite these successes, signiﬁcant interspecies differences exist
between human and mouse HFs not only in their hair cycles,
stem cell characteristics, and hormonal dependencies23, but also
in the hair inductive properties of their dermal cells. One striking
difference is that cultured rodent DPCs can self-aggregate when
transplanted onto rodent skin24; however, this aggregative beha-
vior is not observed in human DPCs25. In a study from
Toyoshima et al., human HFs were induced in mice by using a
hair germ-like 3D culture method by mixing bulge region-derived
epithelial cells and scalp HF-derived intact DPCs6. This study
represented a valuable proof-of-concept that human DPCs can
generate HFs in vivo. However, to translate and scale such an
approach into a clinical reality, these cells must be expanded
in vitro for several passages, which causes a rapid loss of hair
inductive gene signature in DPCs7,8.
We recently addressed this issue by 3D-spheroid culture of
cells and thereby restored 22% of the hair inductive DPC gene
signature. Subsequently, other groups also reported the use of this
method to induce HFs in mice, albeit inefﬁciently11. To enhance
the efﬁciency of hair induction properties, in this study, we
combined genetic and microenvironmental reprogramming
strategies by overexpressing the MR gene Lef-1 in combination
with spontaneous DPC spheroid formation in the HSCs, which
resulted in 70% success rate of HF formation ex vivo, compared
to only 19% with the empty vector-transfected DPCs.
Vascularizing and grafting these HSCs led to efﬁcient induction
of human HF formation in mice. Although our MR strategy
signiﬁcantly enhanced the hair lineage differentiation in vitro, the
efﬁciency of hair growth with a fully developed hair shaft was
much higher in the grafted HSCs compared to in vitro cultured
HSCs, reﬂecting the limitations of the in vitro/ex vivo approach in
terms of the culture conditions. This will be addressed in the
future by leveraging appropriate growth factors, small molecules
or proliferation enhancers.
Tissue-engineered human HFs have many compelling appli-
cations including: (i) skin replacement therapy for full-thickness
skin loss; (ii) hair restoration surgery; (iii) substituting/com-
plementing animal models of hair disease for drug development;
and (iv) testing of cosmetic products. Our method has several
advantages over previous approaches, which rely on spontaneous
formation of HFs6,22, especially in terms of the ability to control
the pattern and density of the follicles, and to use expanded
primary cells (>passage 3) yielding sufﬁcient number of cells for
any type of application. For example, for third degree burn
patients that require full-thickness skin grafts, spatial control over
HFs may facilitate recreating the variations in hair density at the
site of transplantation (e.g. 292 HF per cm2 in forehead vs.18 HF
per cm2 in forearms13). Interestingly, Plikus et al. recently showed
that BMP signaling from HFs can convert myoﬁbroblasts into
adipocytes and potentially reduce scar formation after wound-
ing26. The presence of HFs in our HSCs may enable this function
by promoting adipocyte differentiation in the wound bed,
although this requires further investigation. In addition, the for-
mation of a scar or nonfunctional skin is typically observed in
skin grafts due to poor viability and integration of HSCs27,28. Our
ability to vascularize hair-bearing HSCs will signiﬁcantly promote
the viability of both the skin and hair tissues, constituting a
groundbreaking innovation for regenerative skin therapies.
Robotic hair restoration surgery has revolutionized modern
hair transplantation by allowing for performing repetitive man-
euvers within high precision and speed29. Hair restoration sur-
gery to treat male and female pattern baldness usually requires
100 cm2 of donor tissue site to deliver nearly 2000 grafts (~4400
hairs) per patient. Using our strategy, we typically generate 15
million DPCs (passage 3) from a strip of donor tissue as small as
0.5 cm2, yielding enough cells to produce more than 5000 HFs in
our HSCs, making it a feasible and efﬁcient strategy to integrate
with hair restoration therapy. The improvements of these robotic
systems to harvest hair follicular units (groups of 1–4 hairs), as
opposed to single hairs, yield signiﬁcantly more hair growth per
harvest30. Using 3D-printing approaches, our goal is to engineer
HFs as follicular units and/or in desired patterns that can be
integrated with surgical robots and facilitate effective hair trans-
plantation surgery. Moreover, from a technical perspective, har-
vesting HFs with an obtuse angle, compared to 90 degrees, is
more challenging and typically requires larger incisions31. In our
3D-printing approach, we used a starting HF angle of 90 degrees,
which is then self-reorganized within the constructs above 120
degrees after 3 weeks of culture or skin grafting. However, for hair
restoration applications, we envision that HFUs in our hair
constructs can be harvested as soon as a week after their pre-
paration, providing a more practical starting material to harvest
HFs with a straight incision perpendicular to the epidermis.
Organ culture of HFs is still the current gold standard for drug
testing on human HFs. This method has several limitations
including its low-throughput, dependence on fresh, living HFs
from human donors, difﬁcult to standardize due to wide inter-
individual variation in rates of hair growth (due to different
human donors), inability to capture the signaling from the dermis
(e.g. dermal ﬁbroblasts and endothelial cells), and the short life-
span of the cultures. Our ability to incorporate engineered HFs
into HSCs represents the ﬁrst major step to circumvent some of
these limitations. We are currently able to make nine skin con-
structs containing 255 HFs in a six-well-plate format starting
from only one HF donor tissue, which is a substantial improve-
ment on the throughput aspect of drug testing (1:1 in the orga-
notypic assay). In addition, the contribution of the dermal
compartment on the HFs can potentially be examined especially
with the addition of other dermal components in the future such
as immune cells.
One of the immediate extensions of our approach will be the
incorporation of melanocytes to generate pigmented HFs. We
previously derived melanocytes from iPSCs, and showed their
capability to transfer their melanin to neighboring keratino-
cytes32. Moreover, in our analyses we did not examine the cap-
ability of these engineered HFs to undergo the hair cycle, which
relies on the presence and maintenance of a reservoir of stem cells
in our HSCs. Recently, De Luca’s group demonstrated that
holoclonal epidermal stem cells33, a subpopulation of cultured
KCs with a high self-renewal capacity, are capable of regenerating
the entire human epidermis34. The ability to maintain the holo-
clonal epidermal stem cells in a feeder-free environment over
several passages, as well as within HSCs over long periods, could
provide greater regenerative capacity to engineered HFs for
translational purposes. Alternatively, incorporation of HF stem
cells35,36 or iPSC-derived folliculogenic epidermal cells37 sepa-
rately into HSCs could potentially establish the hair cycle.
However, adding a stem cell niche, such as the bulge region,
containing HF stem cells into our constructs will require better
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07579-y
8 NATURE COMMUNICATIONS |          (2018) 9:5301 | DOI: 10.1038/s41467-018-07579-y | www.nature.com/naturecommunications
resolution in the spatial control of cells, which is a current
technical limitation of our method utilizing 3D-printed molds. In
the future, 3D-bioprinting technology operating at a single cell
resolution may permit the inclusion of other cell types, such as
stem cells and melanocytes, to generate cycling and pigmented
HFs.
A recent study revealed that hair organoid formation of mouse
cells in vitro follows a different self-organization mechanism than
what occurs during hair morphogenesis, despite resulting in
successful hair growth in vivo21. In agreement with this ﬁnding,
our approach exploits the epidermal−mesenchymal interactions
during hair development while synthetically guiding the physio-
logical conformation and reconstituting the gene signature of
cultured cells to induce human hair growth in vitro and in mice.
Our novel biomimetic developmental tissue engineering strat-
egy represents a crucial step forward in generating a truly func-
tional human skin and marks a dramatic conceptual advance in
regenerative medicine approaches to disorders of the skin and
HF, as well as improving the outcome of severe skin injuries
leading to disﬁguring scars. Adaptation of this new technology by
hair researchers, hair restoration surgeons and the pharmaceu-
tical and cosmetic industries will have overwhelming implications
in the maintenance and regeneration of this complex human
tissue.
Methods
Cell isolation and culture. Neonatal dermal keratinocytes and ﬁbroblasts were
isolated from human foreskin and cultured in CnT-07 (CELLnTEC) up to passage
3 (P.3) and in Dulbecco Modiﬁed Eagle Medium (DMEM) with 10% Fetal Bovine
Serum (FBS) up to P.5, respectively. GFP-tagged HUVECs (Angio-proteomie) were
cultured in tissue culture ﬂasks coated with a quick coating solution (Angio-pro-
teomie) and maintained in endothelial cell growth medium (EGM, Angio-pro-
teomie). DPCs were isolated from discarded scalp tissues from hair restoration
surgery (kindly provided by Dr. Robert Bernstein) using microdissection38, and
cultured in DMEM with 10% FBS up to P.3. Culture medium was changed every
other day for all cell types. The cells were kept in a humidiﬁed incubator at 37 °C
and 5% CO2.
Generation of HSCs with hair follicle patterns. All 3D-printed molds were
designed and drawn using the computer-aided design (CAD) software, Solidworks.
Each HF-like extension on the molds was 500 μm in diameter and 4 mm in length.
The molds with varying hair densities (19, 81, 255 HFs per cm2) were 3D-printed
using Objet24 3D-Printer (Stratasys) which uses a UV-curing material VeroWhite
(Stratasys). 3D skin constructs were generated in six-well-plate transwell inserts
similar to the method described previously39. The dermal compartment was pre-
pared by adding 4 mL of type I collagen matrix containing 1.25 × 105 ﬁbroblasts per
ml into the transwell inserts and polymerized around the 3D-printed HF molds
placed on top of the gel at 37 °C for 30 mins. After complete polymerization, the
molds were removed and 100 μl of DPC cell suspension at a density to give 3000
DPCs per microwell was added on top of the gel (e.g. 7 million cells per ml for 255
HF per cm2). The constructs were cultured overnight in DMEM with 10% FBS for
aggregate formation, after which 1 million KCs were added on top of the gel. The
constructs were maintained in low calcium epidermilization medium39 submerged
for 1–3 weeks.
Vascularization of the HSCs. GFP-tagged HUVECs were encapsulated in collagen
type I gel at a concentration of 2 million cells per ml to give a HUVEC to FB ratio
of 16:1. After removal of the 3D-printed molds, HSCs were ﬁrst left in EGM-2
medium kit supplemented with growth factors (Lonza) for 3 days for capillary
formation. The DPC and KCs cell seeding were performed as described above.
After a day of culture in a 1:1 mixture of EGM-2 and the epidermilization medium,
the constructs were either imaged or used for grafting experiments.
Histology, immunostaining, and imaging. For immunostaining and histological
staining, samples were cut in half and embedded in parafﬁn wax or cryopreserved
in OCT solution. Formalin (10%)-ﬁxed, parafﬁn wax-embedded tissues were cut
(20 µm) onto poly-L-lysine-coated slides, dried overnight at 55 °C, dewaxed in
xylene and rehydrated through a graduated ethanol series (100, 95, 70%) and
distilled water (dH2O). Samples were rinsed brieﬂy with phosphate-buffered saline
(PBS) and blocked using 2% ﬁsh skin gelatin (Sigma) in PBS containing 0.025%
Triton-X-100 for 90 min at RT. Samples were incubated with primary antibodies
(see the list of antibodies and dilutions used in Supplementary Table 2) overnight
at 4 °C. After washing with PBS, samples were incubated with ﬂuorophore-
conjugated secondary antibodies (Donkey anti-Rabbit 594, and Goat anti-mouse
488, 1:700, Invitrogen) for 2 h at RT. Slides were covered with cover-slips using
mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Vecta-
shield) and examined using a Zeiss LSM 5 Exciter confocal laser scanning
microscope. ALP staining was performed using the VactaShield ALP activity kit
following the manufacturer’s instructions. Wholemount tissue staining was per-
formed similarly to the staining of the sections except that the tissues were incu-
bated in the primary antibody for 3 days and the secondary antibody overnight.
The tissue was cleared by benzyl alcohol to benzyl benzoate mixture (1:2) before
imaging.
Haematoxylin and eosin staining (H&E). Dewaxed 20 µm sections were stained
with Mayer’s Haematoxylin (Sigma) at RT for 3 min. Blue staining was performed
by rinsing in tap water, while differentiation was achieved by rinsing in 1% acid
ethanol. Counterstaining was performed by rinsing with eosin (Sigma) for 30 s and
dehydration was performed by sequential washing with 95% ethanol, 100% ethanol
and Histo-Clear (National Diagnostics). Slides were covered with cover-slips with
DPX (Agar Scientiﬁc) and examined by light microscopy using a Zeiss Axioplan 2
microscope.
HSC engraftment onto mice. All experimental animal protocols were approved by
the Institutional Animal Care and Use Committee at Columbia University Medical
Center. 0.8 cm2 of skin was removed from the dorsal antero-posterior midline
surface of 8–10-week-old, male immunodeﬁcient nude mice (athymic nude, Crl:
NU(NCr)-Foxn1nu, Charles River, Wilmington, MA) using the pinch cutting
technique. A silicone chamber with a diameter and height of 1 cm was inserted
underneath the skin on the back of the mouse. Only one chamber was placed on
each mouse. The chamber was hat shaped, with a hole in the top of the hat. The
HSCs were placed into the chambers and maintained for 5 days by adding epi-
dermalization medium everyday into the chamber. Subsequently the chamber was
removed and the HSCs were secured with four sutures (7–0 Nylon) in a simple
interrupted pattern around the edge of the graft. A Bandaid was then wrapped
around the mice (an OpSite Flexiﬁx Transparent Film) to hold the graft in place.
The mice were euthanized after 4–6 weeks for analyses. To visualize the vascu-
larization, the mice were injected intravenously through tail vein with mouse-
speciﬁc rhodamine-conjugated GS-IB4 (1:10; Invitrogen) solution 20 min prior to
euthanasia40. The engraftment experiments were performed using ﬁve biological
replicates (separate batches of HSCs) on two mice per each biological replicate
(n= 10) per condition.
Transfection of DPCs. The plasmids pBABE-puro LEF1 (Addgene, #27023) and
pCMV3-FLI1 (Sino Biological, HG14507-UT) were purchased. DPCs at passage 3
were seeded in six-well plates at 100,000 cells per well and cultured overnight prior
to transfection. Lipofectamine P3000 transfection reagent was used to transfect the
cells. In each well, the cells were maintained in 250 µl of P3000 with 2.5 µg of DNA
overnight and the medium was changed to normal culture medium for further use
or analyses.
RNA-sequencing. Total RNA was isolated from cells maintained at indicated
conditions by using the RNeasy Mini Kit (Qiagen) in accordance with the man-
ufacturer’s instructions. Only the total RNA that received an RNA integrity
number (RIN) of 9 or higher was submitted for RNA-sequencing to the Columbia
University sequencing facility. Samples were processed at 30 million reads per
sample. For the sequencing analysis, reads were aligned to the human reference
genome (hg19). Gene counts were calculated using HTSeq and were used as an
input for differential gene expression analysis with DESeq (version 1.20.0). Com-
paring the 2D cultured DPCs with the intact DPCs, genes with a p value (two-tailed
t test) of less than 0.05 as well as a twofold change were chosen for further analysis.
Gene expression data of the samples clustered in heatmaps and gene distance
matrix were performed using unsupervised hierarchical gene clustering analyses.
Gene set enrichment analyses. We previously identiﬁed MRs of DPC gene sig-
nature by interrogating the skin transcriptome for panel enrichment and associa-
tions of differential expression using both Fisher’s Exact Test and GSEA, to identify
transcription factors with an enriched set of targets within a particular territory.
Here, the GSEA was used to compare the Lef-1-targeted genes previously detected
by ARACNE algorithm7 to the gene expression data found experimentally by
RNA-sequencing in Lef-1-transfected DPCs. A null distribution for calculating the
NES and its associated p value was found by label shufﬂing to randomize the gene
rankings. These randomized sets were then used to calculate null ESs over 10,000
iterations to generate a null distribution. The observed leading-edge ES was nor-
malized to this null distribution, and a two-tailed p value was generated for this
NES.
Real-time PCR and statistical analyses. To collect RNA from HSCs, the whole
tissue was ﬁrst homogenized by a sonicator in Trizol prior to RNA extraction.
cDNA was generated from RNA samples following Invitrogen protocols and using
SuperScript III with a mixture of random hexamers and oligo dT primers. qPCR
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was performed using Sybr Green PCR mix on an Applied Biosystems 7300 Real-
Time PCR System. Fold changes were calculated using the delta-delta CT algo-
rithm. Error bars were calculated based on SD across three technical replicates
within three biological replicates. An unpaired two-tailed t test was used to cal-
culate whether differences between samples, across three technical replicates, were
signiﬁcant, or p < 0.05. Primer sequences are available in Supplementary Table 1.
Laser capture microdissection. Laser capture microdissection was performed at
Columbia University Cancer Center Core Facility using a laser capture microscope
(Arcturus Engineering, Mountain View, CA, USA). OCT-embedded samples were
sectioned on membrane slides at a thickness of 5 μm, ﬁxed in 75% ethanol, and
dehydrated in xylene prior to microdissection41. The captured tissue was imme-
diately lysed and prepared for further PCR analyses.
Statistics. The statistical analysis was performed for all the experiments using two-
tailed paired t test with 95% conﬁdence interval with the software GraphPad Prism.
Since we used four different cell types in our engineered tissues and anticipated
variabilities between different donors, we chose an adequate sample size by using at
least three biological replicates and three technical replicates throughput the study.
In particular, the experiments done for establishing HF differentiation in hair
constructs in vitro were performed in triplicates using cells from the foreskin of
three different donors (biological replicates). qPCR analyses and quantiﬁcation of
the success rate of hair differentiation in vitro was done in triplicates and with three
biological replicates for each condition. For the calculations of in vivo success ratio,
the engraftment experiments were performed using ﬁve biological replicates
(separate batches of HSCs) on two mice per each biological replicate (n= 10) per
condition, yielding a total of 20 mice. The hair regeneration success ratio was based
on the vascularized grafts that were viable at the time of harvesting. The researcher
who performed the quantiﬁcation of success rates shown in Fig. 3 was blinded.
RNA-seq data collection was performed by a separate core facility at Columbia
Genome Center and analyzed without a prior knowledge of the conditions of the
samples. No randomization was used. For all statistical analyses, p < 0.05 was
considered signiﬁcantly different, where the *p < 0.05 and **p < 0.005. Data were
shown as means ± s.e.m.
Data availability
Data supporting the ﬁndings of this study are within this manuscript or available
from the corresponding authors upon reasonable request. The RNA-seq data have
been submitted to the GEO database under the accession code GSE121112.
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